← Back to home

PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT

Clinical trials for PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT explained in plain language.

Never miss a new study

Get alerted when new PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT trials appear

Sign up with your email to follow new studies for PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for lung cancer patients with devastating brain spread

Disease control Not yet recruiting

This early-stage study is testing whether adding a new drug called Zorifertinib to a standard treatment (Osimertinib) is safe and effective. It is for adults with a specific type of advanced lung cancer where the disease has spread to the protective membranes around the brain and…

Matched conditions: PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT

Phase: PHASE1 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT

Get alerted when new PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER WITH MENINGEAL PROGRESSION AFTER OSIMERTINIB TREATMENT trials appear

New hope for lung cancer patients with devastating brain spread